Can of worms [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2020-01-30 14:12 (472 d 06:41 ago) – Posting: # 21105
Views: 3,009

Hi jag,

I agree with Helmut.
My top three for scientific advice is Sweden, Sweden, and Sweden.
You will of course not fall for the temptation to take sc. advice in the countries which are the most attractive business-wise.

It will likely be a 10(3). This is Europe, so if the study is conducted here you will be facing an IEC, not IRB, technically. And note that the IEC may be a bottle-neck. They can say no, even if the authority will say yes.

Try and discuss the case with different CROs, I think you find that several of them (in EU their numbers are limited) have been in situation before and have been discussing the matter with other sponsors + authorities as well as with IECs.
What are you actually going to measure? :-)

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,462 posts in 4,487 threads, 1,514 registered users;
online 17 (0 registered, 17 guests [including 13 identified bots]).
Forum time: Sunday 20:53 UTC (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5